[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-KRRO":3,"homepage-market-summary":31,"stock-news-KRRO":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"KRRO","2026-10-05",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Korro Bio, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.","57","Cambridge, MA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},9.97,9.7,10.1,9.41,9.64,0.33,3.42,112181.488565,2359,9.8269,55.89,5.204,274124.89907935855,9.4,1760,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":153},"success",[34,42,49,56,63,69],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7773.95,51.23,0.66,true,"0.0,8.3 2.3,10.7 4.6,13.5 6.9,9.4 9.3,11.7 11.6,13.9 13.9,16.0 16.2,10.6 18.5,9.8 20.8,2.6 23.2,2.6 25.5,6.3 27.8,6.4 30.1,3.9 32.4,7.7 34.7,8.5 37.1,9.7 39.4,8.8 41.7,5.2 44.0,2.0",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",31076.44,268.51,0.87,"0.0,12.3 2.3,12.8 4.6,14.9 6.9,13.2 9.3,14.8 11.6,16.0 13.9,16.0 16.2,12.7 18.5,11.4 20.8,5.9 23.2,4.3 25.5,6.0 27.8,5.9 30.1,5.1 32.4,7.2 34.7,6.8 37.1,6.4 39.4,5.8 41.7,3.8 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51268,91,0.18,"0.0,2.0 2.3,5.0 4.6,7.4 6.9,3.6 9.3,4.7 11.6,7.2 13.9,11.9 16.2,9.5 18.5,10.2 20.8,7.5 23.2,8.9 25.5,11.5 27.8,12.7 30.1,9.1 32.4,11.7 34.7,12.7 37.1,16.0 39.4,15.8 41.7,14.0 44.0,13.3",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27477.31,286.45,1.05,"0.0,11.9 2.3,13.4 4.6,15.0 6.9,12.7 9.3,14.1 11.6,16.0 13.9,16.0 16.2,11.9 18.5,10.9 20.8,5.3 23.2,4.2 25.5,7.1 27.8,7.0 30.1,5.8 32.4,8.1 34.7,8.3 37.1,7.8 39.4,7.7 41.7,4.7 44.0,2.0",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":39,"is_up":40,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2833.8,18.6,"0.0,2.0 2.3,5.4 4.6,7.8 6.9,6.8 9.3,8.3 11.6,10.0 13.9,11.0 16.2,9.7 18.5,10.8 20.8,9.6 23.2,8.2 25.5,12.6 27.8,12.9 30.1,12.6 32.4,14.2 34.7,15.1 37.1,16.0 39.4,15.1 41.7,13.0 44.0,11.4",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":40,"sparkline":75,"date":5},"VIX","CBOE VIX",15.52,0.21,1.37,"0.0,10.2 2.3,7.3 4.6,2.0 6.9,9.7 9.3,4.9 11.6,4.5 13.9,2.5 16.2,11.3 18.5,13.7 20.8,13.5 23.2,16.0 25.5,12.3 27.8,10.4 30.1,13.5 32.4,8.8 34.7,8.9 37.1,7.8 39.4,7.6 41.7,11.8 44.0,10.9",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":40,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",238.9,4.95,2.12,"0.0,16.0 7.3,12.2 14.7,13.8 22.0,12.6 29.3,10.1 36.7,7.0 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":14,"sparkline":90,"date":5},"AAPL","Apple Inc",332.89,-0.8,-0.24,"0.0,2.0 7.3,5.2 14.7,16.0 22.0,11.7 29.3,14.9 36.7,10.9 44.0,11.8",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":40,"sparkline":97,"date":5},"TSLA","Tesla Inc",378.69,8.1,2.18,"0.0,5.6 7.3,13.5 14.7,16.0 22.0,14.9 29.3,15.3 36.7,6.4 44.0,2.0",[99,104,109,114,119,124,129,134,139,144,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":40},"Technology","XLK",0.56,200.93,{"name":105,"etf":106,"change":107,"price":108,"is_up":40},"Financials","XLF",0.73,53.88,{"name":110,"etf":111,"change":112,"price":113,"is_up":40},"Healthcare","XLV",0.72,167.37,{"name":115,"etf":116,"change":117,"price":118,"is_up":40},"Consumer Cycl","XLY",0.35,110.42,{"name":120,"etf":121,"change":122,"price":123,"is_up":40},"Consumer Staples","XLP",0.63,81.04,{"name":125,"etf":126,"change":127,"price":128,"is_up":40},"Energy","XLE",0.99,63.44,{"name":130,"etf":131,"change":132,"price":133,"is_up":40},"Industrials","XLI",0.09,170.1,{"name":135,"etf":136,"change":137,"price":138,"is_up":40},"Materials","XLB",1.31,49.5,{"name":140,"etf":141,"change":142,"price":143,"is_up":14},"Real Estate","XLRE",-0.34,40.67,{"name":145,"etf":146,"change":117,"price":147,"is_up":40},"Utilities","XLU",39.97,{"name":149,"etf":150,"change":151,"price":152,"is_up":40},"Comm Services","XLC",1.17,111.61,[154,159,164,169],{"ticker":155,"name":156,"price":157,"change":158,"is_up":40},"SPY","SPDR S&P 500 ETF",774.83,0.67,{"ticker":160,"name":161,"price":162,"change":163,"is_up":40},"QQQ","Invesco QQQ Trust",756.2,0.88,{"ticker":165,"name":166,"price":167,"change":168,"is_up":40},"DIA","SPDR Dow Jones ETF",512.11,0.2,{"ticker":170,"name":171,"price":172,"change":39,"is_up":40},"IWM","iShares Russell 2000",283.39,{"ticker":4,"count":174,"articles":175},5,[176,182,188,194,199],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"(KRRO) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiywFBVV95cUxOc1NodDFfVnZFZjdldGlfYmRlaE92Rlp5VmkxNDB6d2pRZ1BEX3R5UTlKdzlRMlp3ZnpSY0tLVmRJTEt0ZHNkQjRoSlhxbVluQnVhWDdUcXJRRFRuVEVQTEtHSmRESldzV0FTUGM1U2xvY0o1RGNrMDZfcjBPMEZobDR1NzVZTzlEUzBqRmdWWmF1RXR6b2RJbDZrQl9XaFV0MDZjXzdkbmdqZEVSU2VUSXM1bUNFVE52b0tENXNxVFB0dkRyS2pkLTFYVQ?oc=5","Tue, 06 Oct 2026 09:58:02 GMT","(KRRO) as a Liquidity Pulse for Institutional Tactics news.stocktradersdaily.com","news.stocktradersdaily.com",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"HC Wainwright & Co. reiterates Buy rating on Korro Bio, $15 price target - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxOZHBRYTRVa1doZy11NkVoRFB6MG5WMlp4ZDhXNjRkdFRhQXNISUhJa2w4bjhlR01PNVB0Q3pRUDNDMzYxdDdfejVnMUpHV2o5em05SVhxRXlPUXd5dW5SZlVKQXBQOFNMd3BKOWJfZGYwdHQyems1Y0pnZXA0ZjhsaEtZNTlGaF95VGpCUTFLYmxRZU5nZWdzSkFYbVNmcHZQNlY2ZlROYzQ4bk51Ymx2R0tVNlA3c3o5YkF0T2JWekl2aTBYMHlLWA?oc=5","Tue, 06 Oct 2026 10:16:10 GMT","HC Wainwright & Co. reiterates Buy rating on Korro Bio, $15 price target TradingView","TradingView",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"H.C. Wainwright reiterates Korro Bio stock rating on trial dosing - Investing.com India","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwgFBVV95cUxNOVQzbC1GYmZYOEo4dVg3SlFTZ3otQ1JtZGNrTmQwcmVGUHlyRlQxRTlscHhtUWpWMzFDNUJtTkUxRWh3S1pvQnhrbzk1aEdobi01Um1XNnRBV2FnVlVTMUJuSFRBWnRCQldZa0V3dEF3Z2pUdWNJQ2F0SXR3eXBKUUlQYmI4Z1dxVm92QTJkdm5nakVJTTBtVGNFMlhPeFA5RlEtX2JRUHozcWNPMDMxckM5b3FmUVRyd2pkV1ltb25Ndw?oc=5","Tue, 06 Oct 2026 11:53:25 GMT","H.C. Wainwright reiterates Korro Bio stock rating on trial dosing Investing.com India","Investing.com India",{"title":195,"link":196,"pubDate":197,"description":198,"source":193},"Korro Bio doses first patients in urea cycle disorder trial By Investing.com - Investing.com India","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxQYWk1MHc1ckpwMjI3eF9nRXRkZjJsbDNKdlhJZnlLLURiN0pHd2RxQUlzOWxKdlcwTDlhV3RVMDMxX09ZYmhtU29LdkQyRkVJZTJESWowVFE4dG5RcGVNa0k0WUZWVHR1Q3E4MEhFYmxLUzAyMzdfeE5wNVNCZHVNX3BabHVHUjIyRHNJY2dCbGgyNkptaWFST015Q1dSVkNFRzJjS0VxUFRoRGNzaGtHSjRoUnN0T3dWS2otZQ?oc=5","Mon, 05 Oct 2026 20:17:31 GMT","Korro Bio doses first patients in urea cycle disorder trial By Investing.com Investing.com India",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"Korro Bio Begins First Human Trial of KRRO-121 Therapy - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqgFBVV95cUxPUXRsLWF4bHMxN2lRV1JnU2FRQW5XZlAyeG5uam5kMmxVdmhJYmdxbDR4cWQyekp3NGRYdzZFNWpDQ2F6bXVLMVh6bmxUWG1abWhKM05lVTNXcUJubC1BcHNXMDdKQ1FaeUo5RmR0RzkwbUtyR1BLRWJzM2NUdUJ1bHBuNVlVVGFrQTdoWU5DUWRTc2FnOTJfZ19WNE9jaVpwZjcyeUdJcVZxZw?oc=5","Mon, 05 Oct 2026 20:43:21 GMT","Korro Bio Begins First Human Trial of KRRO-121 Therapy TipRanks","TipRanks"]